Evidence supporting the role of DNA pyridyloxobutylation in rat nasal carcinogenesis by tobacco-specific nitrosamines.

The tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) both induce nasal tumors in rats and have a common metabolic activation pathway leading to pyridyloxobutylation of DNA. The role of DNA pyridyloxobutylation in rat nasal carcinogenesis has not been evaluated previously. In this study, we used gas chromatography-mass spectrometry to compare levels of 4-hydroxyl-1-(3-pyridyl)-1-butanone-releasing adducts formed by pyridyloxobutylation of rat nasal mucosa DNA after treatment with either NNK, NNN, or deuterated analogues of NNK. The latter were [4,4-D2]NNK, a stronger nasal cavity carcinogen than NNK, and [CD3]NNK, which has carcinogenic activity equivalent to NNK. We also investigated toxicity to the nasal mucosa and levels of O6-methylguanine in the DNA of this tissue in rats treated with NNK and its deuterated analogues. Rats were given three times weekly s.c. injections of the respective nitrosamines for 4 weeks and then sacrificed 24 h after the final injection. The nasal mucosa was separated into the olfactory and respiratory portions. In the rats treated with [4,4-D2]NNK, levels of O6-methylguanine in DNA from both the olfactory and respiratory portions of the nasal mucosa were significantly lower and levels of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts higher than in the rats treated with equivalent doses of the less carcinogenic compounds NNK or [CD3]NNK. 4-Hydroxy-1-(3-pyridyl)-1-butanone-releasing adducts were also detected in the nasal mucosa DNA of the rats treated with NNN. In the comparative study of NNK and its deuterated analogues, the histology of the nasal mucosa did not appear to be markedly different among these groups. Collectively, the results of this study provide strong evidence that DNA pyridyloxobutylation is important in rat nasal cavity carcinogenesis by NNK and NNN.

[1]  S. Hecht,et al.  Tobacco-specific nitrosamines. , 1994, IARC scientific publications.

[2]  Z. Ronai,et al.  G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. , 1993, Carcinogenesis.

[3]  S. Hecht,et al.  Pyridyloxobutyl DNA adducts inhibit the repair of O6-methylguanine. , 1993, Cancer research.

[4]  S. Hecht,et al.  Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans. , 1993, Environmental health perspectives.

[5]  Jun-yan Hong,et al.  Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. , 1992, Carcinogenesis.

[6]  Z. Ronai,et al.  Analysis of mutagenic activity and ability to induce replication of polyoma DNA sequences by different model metabolites of the carcinogenic tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1992, Mutation research.

[7]  C. S. Yang,et al.  Deuterium isotope effect on the metabolism of N-nitrosodimethylamine and related compounds by cytochrome P4502E1. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  S. Hecht,et al.  O6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. , 1991, Cancer research.

[9]  J. Resau,et al.  Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. , 1991, Chemical research in toxicology.

[10]  P. Thomas,et al.  Metabolism of carcinogenic nitrosamines by rat nasal mucosa and the effect of diallyl sulfide. , 1991, Cancer research.

[11]  S. Belinsky,et al.  Role of Clara cells and type II cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine. , 1991, Experimental lung research.

[12]  S. Hecht,et al.  Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. , 1990, Cancer research.

[13]  S. Hecht,et al.  Solvolysis of model compounds for alpha-hydroxylation of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: evidence for a cyclic oxonium ion intermediate in the alkylation of nucleophiles. , 1990, Chemical research in toxicology.

[14]  S. Belinsky,et al.  Dose-response relationship between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1990, Cancer research.

[15]  S. Hecht,et al.  Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. , 1990, Carcinogenesis.

[16]  S. Murphy.  DNA isolation from small tissue samples using anion-exchange HPLC. , 1989, Carcinogenesis.

[17]  S. Hecht,et al.  Analysis for N2-(pyridyloxobutyl)deoxyguanosine adducts in DNA of tissues exposed to tritium-labeled 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine. , 1989, Chemical research in toxicology.

[18]  D Hoffmann,et al.  The relevance of tobacco-specific nitrosamines to human cancer. , 1989, Cancer surveys.

[19]  S. Hecht,et al.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. , 1988, Carcinogenesis.

[20]  S. Hecht,et al.  Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine. , 1988, Carcinogenesis.

[21]  S. Belinsky,et al.  Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to the tobacco specific nitrosamine 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia. , 1987, Cancer research.

[22]  J. M. Roman,et al.  Deuterium isotope effect on denitrosation and demethylation of N-nitrosodimethylamine by rat liver microsomes. , 1987, Cancer research.

[23]  S. Hecht,et al.  Effects of alpha-deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. , 1987, Carcinogenesis.

[24]  S. Belinsky,et al.  Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. , 1986, Cancer research.

[25]  S. Hecht,et al.  Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. , 1986, Cancer research.

[26]  S. Hecht,et al.  Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. , 1985, Cancer research.

[27]  C. Michejda,et al.  The methyldiazonium ion in water: competition between hydrolysis and proton exchange , 1985 .

[28]  J. Essigmann,et al.  In vivo mutagenesis by O6-methylguanine built into a unique site in a viral genome. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Hecht,et al.  Metabolism of tobacco-specific nitrosamines by cultured rat nasal mucosa. , 1983, Cancer research.

[30]  S. Hecht,et al.  Effects of α-deuterium substitution on the mutagenicity of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)1 , 1983 .

[31]  J. Saavedra,et al.  Relationship between carcinogenicity and in vitro metabolism of nitrosomethylethylamine, nitrosomethyl-N-butylamine, and nitrosomethyl-(2-phenylethyl)amine labeled with deuterium in the methyl and alpha-methylene positions. , 1982, Cancer research.

[32]  S. Hecht,et al.  Metabolic alpha-hydroxylation of N-nitrosomorpholine and 3,3,5,5-tetradeutero-N-nitrosomorpholine in the F344 rat. , 1981, Cancer research.

[33]  S. Hecht,et al.  Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. , 1980, Cancer research.

[34]  R. C. Shank,et al.  Quantitative high-pressure liquid chromatographic analysis of methylated purines in DNA of rats treated with chemical carcinogens. , 1979, Analytical biochemistry.

[35]  S. Hecht,et al.  Chemical Studies on Tobacco Smoke: LI: Studies on Non-Volatile Nitrosamines in Tobacco , 1977 .

[36]  L. Keefer,et al.  Alkylation of nucleic acids of rat liver and lung by deuterated N-nitrosodiethylamine in vivo. , 1971, Journal of the National Cancer Institute.

[37]  W. Lijinsky,et al.  Mechanism of Alkylation of Nucleic Acids by Nitrosodimethylamine , 1968, Nature.

[38]  J. Montgomery,et al.  Synthesis of Potential Anticancer Agents. XXV. Preparation of 6-Alkoxy-2-aminopurines2 , 1960 .